Skip to main navigation
Skip to search
Skip to main content
Pure University (For Demo Only) Home
Help & FAQ
English
中文
Home
Profiles
Research units
Research output
Equipment
Datasets
Activities
Prizes
Impacts
Projects
Press/Media
Search by expertise, name or affiliation
Inhibition of anti-CD3 antibody-induced mouse T cell activation by pentoxifylline in combination with rapamycin or A77 1726 (leflunomide)
Martin Richard,
David W. Hoskin
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibition of anti-CD3 antibody-induced mouse T cell activation by pentoxifylline in combination with rapamycin or A77 1726 (leflunomide)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Mouse
100%
T Cell Activation
100%
Sirolimus
100%
CD3 Antibody
100%
Leflunomide
100%
Pentoxifylline
100%
CD25
18%
CD3 Antigen
13%
Interleukin 2
13%
Killer Cell
13%
Splenocyte
9%
T Cell
4%
Metabolite
4%
Immunotherapy
4%
Mouse Model
4%
IC50
4%
Synergism
4%
Anti-CD3 Monoclonal Antibody
4%
Immunomodulatory Drug
4%
T Cell Proliferation
4%
Lymphocyte Proliferation
4%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
Mouse
100%
Pentoxifylline
100%
CD3 Antibody
100%
Teriflunomide
100%
Leflunomide
100%
Interleukin 2
13%
Synergism
4%
Mouse Model
4%
IC50
4%
Immunotherapy
4%
Cell Culture
4%
Active Metabolite
4%
Combination Drug
4%
Monoclonal Antibody CD3
4%
Keyphrases
Lymphoproliferation
4%